Advanced search
Publication Cover
Epigenomics Volume 3, 2011 - Issue 4
Submit an article Journal homepage
199
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Global DNA Methylation and Tumor Suppressor Gene Promoter Methylation and Gastric Cancer Risk in an Omani Arab Population

Jennifer A Rusiecki1 Department of Preventive Medicine & Biometrics, Uniformed Services University, 4301 Jones Bridge Rd, Bethesda, MD 20814, USA;5 Tel.:+301 295 3712Fax:+301 295 [email protected]
,
Maryam Al-Nabhani2 Department of Biochemistry, College of Medicine & Health Sciences, Sultan Qaboos University (SQU), Muscat, Sultanate of Oman
,
Letizia Tarantini3 Center of Molecular & Genetic Epidemiology, Department of Environmental & Occupational Health, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico & Università degli Studi di Milano, Milan, Italy
,
Ligong Chen1 Department of Preventive Medicine & Biometrics, Uniformed Services University, 4301 Jones Bridge Rd, Bethesda, MD 20814, USA
,
Andrea Baccarelli3 Center of Molecular & Genetic Epidemiology, Department of Environmental & Occupational Health, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico & Università degli Studi di Milano, Milan, Italy
&
Mansour S Al-Moundhri4 Medical Oncology Unit, Department of Medicine, College of Medicine & Health Sciences, Sultan Qaboos University (SQU), Muscat, Sultanate of Oman
Pages 417-429 | Published online: 18 Aug 2011

Bibliography

  • Hohenberger P , GretschelS. Gastric cancer. Lancet362 , 305–315 (2003).
  • Choi I , WuT. Epigenetic alterations in gastric carcinogenesis. Cell Res.15(4) , 247–254 (2005).
  • Ministry of Health Sultanate of Oman. Cancer Incidence in Oman 2007. Department of Surveillance and Non-Communicable Disease Control Directorate General of Health Affairs. Muscat, Oman, 28–31 (2009).
  • Baylin SB , HermanJG, GraffJR, VertinoPM, IssaJP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res.72 , 141–196 (1998).
  • Jones PA , LairdPW. Cancer epigenetics comes of age. Nat. Genet.21(2) , 163–167 (1999).
  • Dunn BK . Hypomethylation: one side of a larger picture. Ann. NY Acad. Sci.983 , 28–42 (2003).
  • Feinberg AP , VogelsteinB. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature301(5895) , 89–92 (1983).
  • Gama-Sosa M , SlagelV, TrewynRet al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11(19) , 6883–6894 (1983).
  • Jurgens B , Schmitz-DragerBJ, SchulzWA. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res.56(24) , 5698–5703 (1996).
  • Takai D , YagiY, HabibN, SugimuraT, UshijimaT. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J. Clin. Oncol.30(7) , 306–309 (2000).
  • Fang JY , XiaoSD, ZhuSS, YuanJM, QiuDK, JiangSJ. Relationship of plasma folic acid and status of DNA methylation in human gastric cancer. J. Gastroenterol.32(2) , 171–175 (1997).
  • Cravo M , PintoR, FidalgoPet al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39(3) , 434–438 (1996).
  • Toyota M , AhujaN, SuzukiHet al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59(21) , 5438–5442 (1999).
  • Cheng YY , YuJ, WongYPet al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br. J. Cancer 97(7) , 895–901 (2007).
  • Ficorella C , CannitaK, RicevutoEet al. P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer. Oncol. Rep. 10(1) , 169–173 (2003).
  • Graziano F , ArduiniF, RuzzoAet al. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer implications for treatment with demethylating drugs. Ann. Oncol. 15(3) , 489–492 (2004).
  • Kim TY , LeeHJ, HwangKSet al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest. 84(4) , 479–484 (2004).
  • Li QL , ItoK, SakakuraCet al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109(1) , 113–124 (2002).
  • Strathdee G . Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol.12(5) , 373–379 (2002).
  • Tamura G . Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia. Histol. Histopathol.19(1) , 221–228 (2004).
  • Tamura G . Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol.12(2) , 192–198 (2006).
  • Sakakura C , HamadaT, MiyagawaKet al. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. Anticancer Res. 29(7) , 2619–2625 (2009).
  • Vogiatzi P , VindigniC, RovielloF, RenieriA, GiordanoA. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J. Cell. Physiol.211(2) , 287–295 (2007).
  • Lima EM , LealMF, BurbanoRRet al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz. J. Med. Biol. Res. 41(6) , 539–543 (2008).
  • Fenoglio-Preiser CM , WangJ, StemmermannGN, NoffsingerA. TP53 and gastric carcinoma: a review. Hum. Mutat.21(3) , 258–270 (2003).
  • Christman JK , SheikhnejadG, DizikM, AbileahS, WainfanE. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis14(4) , 551–557 (1993).
  • Greenblatt MS , BennettWP, HollsteinM, HarrisCC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res.54(18) , 4855–4878 (1994).
  • Pogribny IP , PoirierLA, JamesSJ. Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats. Carcinogenesis16(11) , 2863–2867 (1995).
  • Woodson K , MasonJ, ChoiSWet al. Hypomethylation of p53 in peripheral blood DNA is associated with the development of lung cancer. Cancer Epidemiol. Biomarkers Prev. 10(1) , 69–74 (2001).
  • Wainfan E , PoirierLA. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res.52(Suppl. 7) , S2071–S2077 (1992).
  • Sugai T , HabanoW, EndohMet al. Molecular analysis of gastric differentiated-type intramucosal and submucosal cancers. Int. J. Cancer 127(11) , 2500–2509 (2010).
  • Hou L , WangH, SartoriSet al. Blood leukocyte DNA hypomethylation and gastric cancer risk in a high-risk Polish population. Int. J. Cancer 127(8) , 1866–1874 (2010).
  • Hsiung DT , MarsitCJ, HousemanEAet al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 16(1) , 108–114 (2007).
  • Moore LE , PfeifferRM, PoscabloCet al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case–control study. Lancet Oncol. 9(4) , 359–366 (2008).
  • An Q , LiuY, GaoYet al. Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients. Cancer Lett. 188(1–2) , 109–114 (2002).
  • Bastian PJ , PalapattuGS, LinXet al. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Clin. Cancer Res. 11(11) , 4037–4043 (2005).
  • Goessl C , MullerM, HeicappellR, KrauseH, MillerK. DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann. NY Acad. Sci.945 , 51–58 (2001).
  • Goessl C , MullerM, StraubB, MillerK. DNA alterations in body fluids as molecular tumor markers for urological malignancies. Eur. Urol.41(6) , 668–676 (2002).
  • Hsu HS , ChenTP, HungCHet al. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 110(9) , 2019–2026 (2007).
  • Reibenwein J , PilsD, HorakPet al. Promoter hypermethylation of GSTP1, AR, and 14–3–3σ in serum of prostate cancer patients and its clinical relevance. Prostate 67(4) , 427–432 (2007).
  • Ulivi P , ZoliW, CalistriDet al. p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients. J. Cell. Physiol.206(3) , 611–615 (2006).
  • Abbaszadegan MR , MoavenO, SimaHRet al. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J. Gastroenterol.14(13) , 2055–2060 (2008).
  • Leung WK , ToKF, ChuESet al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br. J. Cancer 92(12) , 2190–2194 (2005).
  • Tan SH , IdaH, LauQCet al. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol. Rep. 18(5) , 1225–1230 (2007).
  • Wang YC , YuZH, LiuCet al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J. Gastroenterol. 14(19) , 3074–3080 (2008).
  • Ramirez JL , TaronM, BalanaCet al. Serum DNA as a tool for cancer patient management. Rocz. Akad. Med. Bialymst. 48 , 34–41 (2003).
  • Al-Moundhri M , AlkindyM, Al-NabhaniMet al. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin-1B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani Arab Population. J. Clin. Gastroenterol. 43(2) , 152–156 (2009).
  • Al-Moundhri M , Al-ShukailiA, Al-NabhaniMet al. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World J. Gastroenterol. 14(24) , 3879–3883 (2008).
  • Yang AS , EstecioMR, DoshiK, KondoY, TajaraEH, IssaJP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res.32(3) , e38 (2004).
  • Bollati V , BaccarelliA, HouLet al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67(3) , 876–880 (2007).
  • Shaw RJ , LiloglouT, RogersSNet al. Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br. J. Cancer 94(4) , 561–568 (2006).
  • SAS Institute Inc., SAS 9.2 Reference Manual. SAS Institute Inc., NC, USA (2009).
  • Chalitchagorn K , ShuangshotiS, HourpaiNet al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23(54) , 8841–8846 (2004).
  • Jiang L , GondaTA, GambleMVet al. Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res. 68(23) , 9900–9908 (2008).
  • Kim YI , ChristmanJK, FleetJCet al. Moderate folate deficiency does not cause global hypomethylation of hepatic and colonic DNA or c-myc-specific hypomethylation of colonic DNA in rats. Am. J. Clin. Nutr. 61(5) , 1083–1090 (1995).
  • Pogribny IP , BasnakianAG, MillerBJ, LopatinaNG, PoirierLA, JamesSJ. Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. Cancer Res.55(9) , 1894–1901 (1995).
  • Obe G , JohannesC, Schulte-FrohlindeD. DNA double-strand breaks induced by sparsely ionizing radiation and endonucleases as critical lesions for cell death, chromosomal aberrations, mutations and oncogenic transformation. Mutagenesis7(1) , 3–12 (1992).
  • House MG , GuoM, EfronDTet al. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J. Gastrointest. Surg. 7(8) , 1004–1014; discussion 1014 (2003).
  • Al-Moundhri MS , Al-NabhaniM, TarantiniL, BaccarelliA, RusieckiJA. The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma. PLoS ONE5(12) , e15585 (2010).
  • Yamada H , ShinmuraK, GotoMet al. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol. Cancer 8(63) , 63 (2009).
  • Yoo EJ , ParkSY, ChoNYet al. Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer. Virchows Arch. 456(6) , 647–652 (2010).
  • Shin CM , KimN, JungYet al. Role of Helicobacter pylori infection in aberrant DNA methylation along multistep gastric carcinogenesis. Cancer Sci. 101(6) , 1337–1346 (2010).
  • Al Riyami AA , AfifiM. Smoking in Oman: prevalence and characteristics of smokers. East Mediterr. Health J.10(4–5) , 600–609 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.